New “Semisynthetic” Anti-Malarial Drug is Unneeded and Sets Dangerous Precedent While Threatening Farmer Livelihoods
By Press Release,
SynBioWatch
| 04. 15. 2013
SynBioWatch Press Release:
For Immediate Release
April 15, 2013
Contact: Lisa Archer, Gopal Dayaneni, or Tina Stevens, , (510) 982-1285, info@SynBioWatch.org
Pharmaceutical giant Sanofi Aventis and Amyris Biotech founder Jay Keasling have announced that they intend to replace the entire world supply of the World Health Organization’s preferred anti-malarial treatment derived from botanical artemisinin with a semisynthetic product which employs synthetic biology, a controversial, unregulated biotechnology.
Speaking at a conference in Cambridge, UK, Keasling said, “Moves are afoot to replace the entire world supply” of artemisinin, which is currently produced by thousands of farmers in Kenya, Tanzania, Madagascar, Mozambique, India, Vietnam and China who cultivate sweet wormwood, the natural source of artemisinin. The statement was confirmed in a release by Sanofi outlining their plan to begin large-scale production.
Currently unregulated, synthetic biology is an extreme form of genetic engineering that involves replacing the genetic material of microbes with entirely artificial human designed gene sequences, resulting in new organisms that are then ‘put to work’ as microbial ‘factories.’
The news raised a host of red flags among civil society organizations concerned...
Related Articles
By Emma McDonald Kennedy
| 04.24.2025
A Review of Eggonomics: The Global Market in Human Eggs and the Donors Who Supply Them by Diane M. Tober
A recent journalistic investigation of the global egg trade at Bloomberg put the industry’s unregulated practices and their exploitative implications back in the spotlight. Diane Tober’s book Eggonomics: The Global Market in Human Eggs and the Donors Who Supply Them, published in October of last year, delves even more deeply into the industry with a thorough examination of egg...
By Anna Louie Sussman, The New York Times | 04.08.2025
Before fertility patients begin the long journey through hormone treatments, egg retrieval, fertilization and — hopefully, if everything goes well — a baby, there’s the paperwork. As a first order of business, would-be parents are typically presented with a form...
By Katrina Northrop, The Washington Post | 04.06.2025
photo via Wikimedia Commons licensed under CC by 3.0
China's most infamous scientist is attempting a comeback. He Jiankui, who went to jail for three years after claiming he had created the world's first genetically altered babies, says he remains...
By Kevin Davies, Genetic Engineering & Biotechnology News | 03.27.2025
Around 2018–19, there was not a bigger science and ethical story than the debate over heritable human genome editing (HHGE) and the scandal over the “CRISPR babies.” The scientist, He Jiankui, who attempted to engineer the germline of human embryos...
